Further to the answer to question S6W-37499 by Jenni Minto on 27 May 2025, for what reason (a) the Sanofy VidPrevtyn COVID-19 vaccine has r…

Sanofi’s VidPrevtyn has not been used in the Scottish Vaccination Programme since winter 2023-24, and is no longer available in the UK. The withdrawal was at the request of the marketing authorisation holder, Sanofi Pasteur, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.It remains Scottish Government policy that Health Boards must make non-mRNA COVID-19 vaccines available to those individuals who are contraindicated to, or allergic to, mRNA vaccines. However, trometamol is used in the manufacture of some vaccines, including the mRNA COVID-19 vaccines and at present there are no non-mRNA products authorised for use in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) available for purchase. Health Boards have contacted all individuals affected to explain the situation.National Services Scotland (NSS) National Procurement team will continue to monitor the non-mRNA market position to see if any non-mRNA options become available for future COVID-19 vaccination programmes.